Showing results (81-90 of 171) with videos related to
Sort By:
Pageof 18
Current Problems in Cancer|June 15, 2010
ACR Appropriateness Criteria: local excision in early-stage rectal cancerWilliam Blackstock, Suzanne M Russo, W Warren Suh, et al.Annals of Surgery|April 26, 2005
Long-term oncologic outcome following preoperative combined modality therapy and total mesorectal excision of locally advanced rectal cancerJose G Guillem, David B Chessin, Alfred M Cohen, et al.Anticancer Research|November 2, 2010
Molecular predictors of combination targeted therapies (cetuximab, bevacizumab) in irinotecan-refractory colorectal cancer (BOND-2 study)Wu Zhang, Mizutomo Azuma, Georg Lurje, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 9, 2014
Association of age with survival in patients with metastatic colorectal cancer: analysis from the ARCAD Clinical Trials ProgramChristopher H Lieu, Lindsay A Renfro, Aimery de Gramont, et al.Molecular Cancer Research : MCR|December 15, 2015
Identification of Targetable Kinase Alterations in Patients with Colorectal Carcinoma That are Preferentially Associated with Wild-Type RAS/RAFJaclyn F Hechtman, Ahmet Zehir, Rona Yaeger, et al.International Journal of Legal Medicine|January 17, 2017
Automatic CT-based finite element model generation for temperature-based death time estimation: feasibility study and sensitivity analysisSebastian Schenkl, Holger Muggenthaler, Michael Hubig, et al.Frontiers in Oncology|January 5, 2026
Sensitivity of metastatic mucinous tailgut cyst adenocarcinoma to gemcitabine and radiation: a case reportMaliha Nusrat, Kenneth H Yu, Laura Tang, et al.Oncotarget|December 10, 2016
MicroRNA-203 predicts human survival after resection of colorectal liver metastasisT Peter Kingham, Hoang C B Nguyen, Jian Zheng, et al.Cancer|October 15, 2013
TRAIL receptor agonist conatumumab with modified FOLFOX6 plus bevacizumab for first-line treatment of metastatic colorectal cancer: A randomized phase 1b/2 trialCharles S Fuchs, Marwan Fakih, Lee Schwartzberg, et al.Clinical Colorectal Cancer|October 15, 2018
FOLFCIS Treatment and Genomic Correlates of Response in Advanced Anal Squamous Cell CancerSebastian Mondaca, Walid K Chatila, David Bates, et al.Pageof 18